Tag

Advertisement

pharma-clinical-trial-box

Nikolai Brun

Affibody presents topline 12-week data

March 20, 2023

Affibody has announced that data …

First patient dosed in Targovax study

March 17, 2023

Targovax has announced that the …

First patient dosed in BerGenBio Phase 1b/2a trial

March 14, 2023

The company has announced that …

Renee-Aguiar-Lucander

Calliditas announces positive topline results

March 13, 2023

Calliditas Therapeutics has announced results …

Magnus Corfitzen

Ascelia Pharma achieves major milestone

February 27, 2023

The company has announced the …

Göran Forsberg Photo Håkan Sandbring

Cantargia advances its TRIFOUR trial

February 27, 2023

The company has reported favorable …

Modus Therapeutics announces positive Phase 1b data

February 22, 2023

Modus Therapeutics has announced positive …

Martin Olin

BerGenBio announces positive Phase 2 data

February 21, 2023

The company has announced topline …

Half of the patients dosed in Guard Therapeutics’ AKITA study

February 14, 2023

Guard Therapeutics have announced that …

Heartseed and Novo Nordisk announce first patient dosed in clinical study

February 13, 2023

Heartseed has successfully dosed the …

Promising preclinical mRNA vaccine data from Evaxion

February 8, 2023

Evaxion Biotech and Pantherna Therapeutics …

Last patient included in AlzeCure’s Phase II trial

February 1, 2023

The last patient has now …

Ultimovacs lab

Ultimovacs completes patient recruitment in Phase II trial

January 23, 2023

Ultimovacs has announced the completed …

Richard Godfrey

IRLAB announces Phase IIb results

January 18, 2023

IRLAB Therapeutics has announced the …

Ultimovacs lab

Cemiplimab to replace pembrolizumab in Ultimovacs trial

December 20, 2022

Ultimovacs has announced that cemiplimab …

Erik Manting

Mendus reports positive trial results

December 14, 2022

Mendus has presented survival data …

1
2
3
···
10